INSULET CORP (PODD) — SEC Filings
Latest SEC filings for INSULET CORP (PODD), explained in plain English.
Sentiment Overview: 1 bullish, 42 neutral, 1 mixed
Recent Filings (44)
-
Insulet Corp Changes Independent Auditor
— 8-K · 2025-12-19T00:00:00.000Z [neutral] Risk: low
On December 15, 2025, Insulet Corporation (INSULET) reported a change in its certifying accountant. The company's Audit Committee dismissed PricewaterhouseCoope -
Insulet Corp Reports Director Departure and Officer Compensation Changes
— 8-K · 2025-12-17T00:00:00.000Z [neutral] Risk: low
On December 11, 2025, Insulet Corporation filed an 8-K report detailing the departure of director Robert E. H. Johnson III. The filing also announced the electi -
Insulet's Revenue Soars, Net Income Dips on Debt Extinguishment
— 10-Q · 2025-11-06T00:00:00.000Z [mixed] Risk: medium
Insulet Corporation (PODD) reported robust revenue growth for the nine months ended September 30, 2025, reaching $1,924.3 million, a significant increase from $ -
Insulet Corp Reports Director Changes and Compensation Updates
— 8-K · 2025-10-23T00:00:00.000Z [neutral] Risk: low
On October 21, 2025, Insulet Corporation (INS) filed an 8-K report detailing changes in its board of directors and executive compensation. The filing includes t -
Insulet Corp Files 8-K: Director, Officer, and Compensation Updates
— 8-K · 2025-09-16T00:00:00.000Z [neutral] Risk: low
On September 11, 2025, Insulet Corporation filed an 8-K report detailing changes in its board of directors and executive officers, along with updates to compens -
Insulet's Q2 Revenue Jumps 21.8%, Net Income Up 29.6%
— 10-Q · 2025-08-07T00:00:00.000Z [bullish] Risk: low
Insulet Corp (PODD) reported robust financial performance for the second quarter ended June 30, 2025, with significant revenue growth and improved net income. T -
Insulet Corp (PODD) Files 8-K: Agreements and Obligations
— 8-K · 2025-06-09T00:00:00.000Z [neutral] Risk: medium
On June 6, 2025, Insulet Corporation entered into a Material Definitive Agreement and also experienced the Termination of a Material Definitive Agreement. The c -
Insulet Corp Files 8-K on Officer Changes and Shareholder Votes
— 8-K · 2025-05-28T00:00:00.000Z [neutral] Risk: low
On May 22, 2025, Insulet Corporation filed an 8-K report detailing several key events. The filing includes information regarding the departure of directors or c -
Insulet Corp. Files Q1 2025 10-Q
— 10-Q · 2025-05-09T00:00:00.000Z [neutral] Risk: medium
Insulet Corp. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 202 -
Insulet Corp Files 8-K on Financials
— 8-K · 2025-05-08T00:00:00.000Z [neutral] Risk: low
On May 8, 2025, Insulet Corporation filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as f -
Insulet Corp Files Definitive Proxy Statement for 2025 Annual Meeting
— DEF 14A · 2025-04-29T00:00:00.000Z [neutral] Risk: low
Insulet Corporation filed its definitive proxy statement (DEF 14A) on April 29, 2025, for its annual meeting on May 22, 2025. The filing details information req -
Insulet Corp. Board Shake-up: New Directors Elected, Two Depart
— 8-K · 2025-04-28T00:00:00.000Z [neutral] Risk: medium
On April 27, 2025, Insulet Corporation filed an 8-K report detailing the departure of two directors, Dr. Robert E. Smith and Ms. Pamela E. Perry, effective Apri -
Insulet Corp Files 8-K/A Amendment
— 8-K/A · 2025-04-09T00:00:00.000Z [neutral] Risk: low
Insulet Corporation filed an amendment (8-K/A) on April 9, 2025, to its previous report dated March 14, 2025. This amendment pertains to the departure of direct -
Insulet Corp Enters Material Definitive Agreement
— 8-K · 2025-03-21T00:00:00.000Z [neutral] Risk: medium
On March 20, 2025, Insulet Corporation entered into a material definitive agreement related to a direct financial obligation. The company, incorporated in Delaw -
Insulet Corp Files 8-K with Exhibits
— 8-K · 2025-03-18T00:00:00.000Z [neutral] Risk: low
On March 18, 2025, Insulet Corporation filed an 8-K report. The filing primarily concerns financial statements and exhibits, and a Regulation FD disclosure. No -
Insulet Corp (PODD) Reports Executive & Director Changes
— 8-K · 2025-03-17T00:00:00.000Z [neutral] Risk: medium
On March 14, 2025, Insulet Corporation filed an 8-K report detailing changes in its executive officers and board of directors. The filing indicates a departure -
Insulet Corp Files 8-K for Material Definitive Agreement
— 8-K · 2025-03-10T00:00:00.000Z [neutral] Risk: medium
On March 7, 2025, Insulet Corporation entered into a material definitive agreement. The filing does not provide specific details about the agreement, its counte -
Insulet Corp Files 2024 10-K
— 10-K · 2025-02-21T00:00:00.000Z [neutral] Risk: medium
Insulet Corporation filed its 2024 10-K on February 21, 2025, reporting its fiscal year ending December 31, 2024. The company, a leader in surgical and medical -
Insulet Corp Files 8-K on Financials
— 8-K · 2025-02-20T00:00:00.000Z [neutral] Risk: low
On February 20, 2025, Insulet Corporation filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as wel -
Insulet Corp Files 8-K
— 8-K · 2024-12-04T00:00:00.000Z [neutral] Risk: low
On December 3, 2024, Insulet Corporation filed an 8-K report to disclose other events and financial statements/exhibits. The filing does not contain specific de - SC 13G/A Filing — SC 13G/A · 2024-11-12T00:00:00.000Z [neutral]
-
Insulet Corp. Files 10-Q for Q3 2024
— 10-Q · 2024-11-08T00:00:00.000Z [neutral] Risk: medium
Insulet Corp. reported its financial results for the period ending September 30, 2024. The company's filing details its financial position and performance, with -
Insulet Corp Files 8-K on Financials
— 8-K · 2024-11-07T00:00:00.000Z [neutral] Risk: low
On November 7, 2024, Insulet Corporation filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well - SC 13G/A Filing — SC 13G/A · 2024-10-07T00:00:00.000Z [neutral]
-
Insulet Corp. Files 10-Q for Q2 2024
— 10-Q · 2024-08-09T00:00:00.000Z [neutral] Risk: medium
Insulet Corp. reported its financial results for the period ending June 30, 2024. The company's filing details its financial position and performance, including -
Insulet Corp Files 8-K on Operations and Financials
— 8-K · 2024-08-08T00:00:00.000Z [neutral] Risk: low
On August 8, 2024, Insulet Corporation filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well a -
Insulet Corp Files 8-K on Material Definitive Agreement
— 8-K · 2024-08-05T00:00:00.000Z [neutral] Risk: medium
On August 2, 2024, Insulet Corporation entered into a Material Definitive Agreement related to a direct financial obligation. The company, incorporated in Delaw -
Insulet Corp Files 8-K on Operations and Financials
— 8-K · 2024-07-26T00:00:00.000Z [neutral] Risk: low
On July 26, 2024, Insulet Corporation filed an 8-K report to disclose information regarding its results of operations and financial condition, as well as financ -
Insulet Corp Files 8-K on Security Holder Vote
— 8-K · 2024-05-28T00:00:00.000Z [neutral] Risk: low
On May 22, 2024, Insulet Corporation filed an 8-K report detailing a submission of matters to a vote of security holders. The filing does not contain specific d -
Insulet Corp Files 8-K for Material Definitive Agreement
— 8-K · 2024-05-20T00:00:00.000Z [neutral] Risk: medium
On May 15, 2024, Insulet Corporation entered into a Material Definitive Agreement. The filing does not provide specific details about the agreement or any assoc -
Insulet Corp Files 10-Q for Q1 2024
— 10-Q · 2024-05-10T00:00:00.000Z [neutral] Risk: medium
Insulet Corporation reported its first quarter 2024 results for the period ending March 31, 2024. The company's filing details its financial position and operat -
Insulet Corp Files 8-K: Financial Update
— 8-K · 2024-05-09T00:00:00.000Z [neutral] Risk: low
On May 9, 2024, Insulet Corporation filed an 8-K report detailing its financial results and operations. The filing includes financial statements and exhibits, p -
Insulet Corp Files 2024 Proxy Statement
— DEF 14A · 2024-04-09T00:00:00.000Z [neutral] Risk: low
Insulet Corporation filed its DEF 14A proxy statement on April 9, 2024, for its annual meeting on May 22, 2024. The filing outlines the information required for -
Insulet Appoints Two New Directors to Board
— 8-K · 2024-03-20T00:00:00.000Z [neutral] Risk: low
On March 20, 2024, Insulet Corporation announced the appointment of two new members to its Board of Directors, Dr. David J. Adair and Ms. Pamela E. Perry. This -
Insulet Corp Files 8-K on Director Changes and Compensation
— 8-K · 2024-03-01T00:00:00.000Z [neutral] Risk: low
On February 26, 2024, Insulet Corporation filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing in -
Insulet Corp Files 2023 10-K, Details Fiscal Year Performance
— 10-K · 2024-02-23T00:00:00.000Z [neutral] Risk: medium
Insulet Corp, a medical device company, filed its 10-K on February 23, 2024, for the fiscal year ending December 31, 2023. The company, based in Acton, MA, oper -
Insulet Files 8-K on Financial Condition and Operations
— 8-K · 2024-02-22T00:00:00.000Z [neutral] Risk: low
Insulet Corporation filed an 8-K on February 22, 2024, to report on its results of operations and financial condition. The filing, under SEC File Number 001-334 - SC 13G/A Filing — SC 13G/A · 2024-02-13T00:00:00.000Z [neutral]
-
Capital Research Global Investors Trims Insulet Stake to 14.3%
— SC 13G/A · 2024-02-09T00:00:00.000Z [neutral] Risk: low
Capital Research Global Investors, a major institutional investor, filed an amended SC 13G/A on February 9, 2024, disclosing a slight decrease in its beneficial -
FMR LLC & Abigail Johnson Hold 8.45% Stake in Insulet Corp
— SC 13G/A · 2024-02-09T00:00:00.000Z [neutral] Risk: low
FMR LLC, a major investment firm, and its principal owner, Abigail P. Johnson, have updated their ownership stake in Insulet Corp. As of February 9, 2024, they -
Wellington Management Amends Insulet Corp (PODD) Stake
— SC 13G/A · 2024-02-08T00:00:00.000Z [neutral] Risk: low
Wellington Management Group LLP, a Massachusetts-based investment firm, filed an amended SC 13G/A on February 8, 2024, indicating their ownership of Insulet Cor -
Insulet Corp Enters Material Agreement, Takes on New Financial Obligation
— 8-K · 2024-01-25T00:00:00.000Z [neutral]
Insulet Corporation, a medical device company, filed an 8-K on January 25, 2024, reporting an "Entry into a Material Definitive Agreement" and the "Creation of -
BlackRock Amends Insulet Corp. Stake, Signals Passive Investment
— SC 13G/A · 2024-01-25T00:00:00.000Z [neutral]
BlackRock Inc. filed an amended SC 13G/A on January 25, 2024, indicating its ownership of Insulet Corporation's common stock as of December 31, 2023. This filin -
Insulet 8-K: Officer Changes, Compensation, Reg FD Disclosure
— 8-K · 2024-01-18T00:00:00.000Z [neutral]
Insulet Corporation filed an 8-K on January 18, 2024, to report on the departure of directors or certain officers, election of directors, appointment of certain